A leading provider of
innovative DNA Screening solutions
Smith Magenis (FLI1)/Miller Dieker Combination LPU007
Smith-Magenis syndrome (SMS) is characterised by mental retardation, neuro-behavioural abnormalities, sleep disturbances, short stature, minor craniofacial and skeletal anomalies, congenital heart defects and renal anomalies. FLI1 and RAI1 have both been recognised as the candidate gene for the phenotype seen in SMS, they are located in the critical region (17p11.2) and deleted in SMS patients.
Miller-Dieker Syndrome (MDS) is characterised by classical lissencephaly, characteristic facial appearance and other birth defects. Isolated lissencephaly sequence (ILS) disorder consists of classical lissencephaly alone and in 40% of patients the same region is deleted. MDS patients always show deletions of the candidate gene LIS1 within the chromosome band 17p13.3. The Smith-Magenis probe acts as a control for Miller-Dieker and vice versa.
Smith-Magenis (FLI1)/Miller-Dieker Probe Combination
Cat. No. LPU 007-S (5 tests)
Cat. No. LPU 007 (10 tests)
This webpage could contain information on product details or information not valid in your country or region. Please be aware that we do not take any responsibility for accessing such information, which may not comply with any legal process, regulation, registration or usage in the country of your origin. If you are a resident of a country other than those to which this site is directed, contact your local Cytocell distributor to obtain the appropriate product information for your country of residence.
Developed &produced in the UK